The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

about

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

Item

http://www.wikidata.org/entity/Q58608209

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

@en

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

@nl

type

Item

label

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

@en

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

@nl

prefLabel

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

@en

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

@nl

P1476

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival

@en

P2093

Anjan K Saha

http://www.w3.org/2001/XMLSchema#string

Danielle E Bolland

http://www.w3.org/2001/XMLSchema#string

David M Markovitz

http://www.w3.org/2001/XMLSchema#string

Karen McLean

http://www.w3.org/2001/XMLSchema#string

Kari E Hacker

http://www.w3.org/2001/XMLSchema#string

Lijun Tan

http://www.w3.org/2001/XMLSchema#string

Yashar S Niknafs

http://www.w3.org/2001/XMLSchema#string

P2860

The human DEK oncogene regulates DNA damage response signaling and repair

The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner

GENCODE: the reference human genome annotation for The ENCODE Project

The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes

Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

Integrated genomic analyses of ovarian carcinoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

P304

1209-1218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEO.2018.10.005

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30412857

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

cancer research

P932

6226625

http://www.w3.org/2001/XMLSchema#string